Amsurg Corp. (AMSG) Receives Average Recommendation of “Buy” from Analysts
Shares of Amsurg Corp. (NASDAQ:AMSG) have been assigned an average rating of “Buy” from the thirteen analysts that are presently covering the company. Three equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $86.00.
A number of research firms recently issued reports on AMSG. Cantor Fitzgerald set a $90.00 target price on shares of Amsurg Corp. and gave the company a “buy” rating in a report on Wednesday, November 2nd. Zacks Investment Research upgraded shares of Amsurg Corp. from a “sell” rating to a “hold” rating in a research note on Friday, November 4th. Mizuho downgraded shares of Amsurg Corp. from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $95.00 to $71.00 in a research note on Wednesday. Wells Fargo & Co. upgraded shares of Amsurg Corp. from a “market perform” rating to an “outperform” rating in a research note on Wednesday, November 2nd. They noted that the move was a valuation call. Finally, KeyCorp reiterated a “positive” rating and set a $87.00 price objective on shares of Amsurg Corp. in a research note on Tuesday, October 4th.
Shares of Amsurg Corp. (NASDAQ:AMSG) opened at 60.74 on Monday. The company’s 50-day moving average is $64.32 and its 200 day moving average is $71.11. The firm has a market capitalization of $3.27 billion, a price-to-earnings ratio of 18.75 and a beta of 0.67. Amsurg Corp. has a 52 week low of $57.32 and a 52 week high of $86.17.
Amsurg Corp. (NASDAQ:AMSG) last released its earnings results on Tuesday, November 1st. The company reported $1.13 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.13. Amsurg Corp. had a net margin of 6.06% and a return on equity of 8.05%. The firm earned $822.20 million during the quarter, compared to the consensus estimate of $770.29 million. During the same period in the previous year, the firm earned $1.03 earnings per share. Amsurg Corp.’s revenue was up 26.5% compared to the same quarter last year. Analysts anticipate that Amsurg Corp. will post $4.31 EPS for the current fiscal year.
In related news, insider Robert Jon Coward sold 7,500 shares of the company’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $63.65, for a total value of $477,375.00. Following the sale, the insider now directly owns 97,507 shares of the company’s stock, valued at $6,206,320.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 2.30% of the stock is currently owned by insiders.
A number of hedge funds have recently bought and sold shares of AMSG. BlackRock Group LTD boosted its stake in Amsurg Corp. by 24.4% in the first quarter. BlackRock Group LTD now owns 38,307 shares of the company’s stock valued at $2,858,000 after buying an additional 7,509 shares in the last quarter. M&T Bank Corp boosted its stake in Amsurg Corp. by 39.8% in the first quarter. M&T Bank Corp now owns 5,538 shares of the company’s stock valued at $413,000 after buying an additional 1,576 shares in the last quarter. State Street Corp boosted its stake in Amsurg Corp. by 3.9% in the first quarter. State Street Corp now owns 1,821,003 shares of the company’s stock valued at $135,849,000 after buying an additional 68,181 shares in the last quarter. UBS Asset Management Americas Inc. boosted its stake in Amsurg Corp. by 288.3% in the first quarter. UBS Asset Management Americas Inc. now owns 135,787 shares of the company’s stock valued at $10,130,000 after buying an additional 100,821 shares in the last quarter. Finally, Geode Capital Management LLC boosted its stake in Amsurg Corp. by 9.6% in the first quarter. Geode Capital Management LLC now owns 383,828 shares of the company’s stock valued at $28,633,000 after buying an additional 33,596 shares in the last quarter. 98.67% of the stock is currently owned by hedge funds and other institutional investors.
About Amsurg Corp.
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Receive News & Stock Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related stocks with our FREE daily email newsletter.